SOL GEL TECHNOLOGIES LTD
NASDAQ: SLGL (Sol-Gel Technologies Ltd.)
Kemas kini terakhir: semalam, 2:40AM69.52
-0.58 (-0.83%)
| Penutupan Terdahulu | 70.10 |
| Jumlah Dagangan | 29,626 |
| Harga / Jualan (P/S) | 118.09 |
| Harga / Buku (P/B) | 4.94 |
| Julat 52 Minggu |
| Margin Keuntungan | -107.77% |
| Margin Operasi (TTM) | -879.63% |
| EPS Cair (TTM) | -4.70 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 121.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.84% |
| Nisbah Semasa (MRQ) | 5.12 |
| Aliran Tunai Operasi (OCF TTM) | -13.89 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -9.91 M |
| Pulangan Atas Aset (ROA TTM) | -26.82% |
| Pulangan Atas Ekuiti (ROE TTM) | -49.39% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Sol-Gel Technologies Ltd. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.00 |
|
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 70.00% |
| % Dimiliki oleh Institusi | 24.29% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Opaleye Management Inc. | 30 Jun 2026 | 500,000 |
| Trails Edge Capital Partners, Lp | 30 Jun 2026 | 139,445 |
| Affinity Asset Advisors, Llc | 30 Jun 2026 | 84,900 |
| Squadron Capital Management Llc | 30 Jun 2026 | 52,000 |
| Stonepine Capital Management, Llc | 30 Jun 2026 | 14,469 |
| Yelin Lapidot Holdings Management Ltd. | 30 Jun 2026 | 10,384 |
| Navellier & Associates Inc | 30 Jun 2026 | 5,785 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |